戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 P) genotyping, RNA expression profiling, and spectral karyotyping.
2  using comparative genomic hybridization and spectral karyotyping.
3 nalyzed 15 early-passage mouse cell lines by spectral karyotyping.
4 mosomes from six cell lines were analyzed by spectral karyotyping, a technique that allows one to vis
5                     Whole-genome scanning by spectral karyotyping allowed instantaneous visualization
6 ng from chromosomes in the primary tumor and spectral karyotyping analysis of derived cell lines iden
7                                              Spectral karyotyping analysis of metaphase chromosomes f
8 s that cooperate with PML-RARA, we performed spectral karyotyping analysis of myeloid leukemias from
9 ith PML-RARA in leukemogenesis, we performed spectral karyotyping analysis of myeloid leukemias from
10 ncreased chromosomal aberrations as shown by spectral karyotyping analysis, suggesting changes beyond
11  as determined by metaphase spread assay and spectral karyotyping analysis.
12 idence of secondary genetic events, by using spectral karyotyping analysis.
13 supported the rate of aneuploidy observed by spectral karyotyping and detected aneuploidy in adult ne
14 alyzed by comparative genomic hybridization, spectral karyotyping and fluorescence in situ hybridizat
15 e observed in the cyclin D1-rescued cells by spectral karyotyping and immunofluorescence.
16                                    Utilizing spectral karyotyping and locus-specific fluorescence in
17                                              Spectral karyotyping and short tandem repeat analysis of
18 H-based technologies such as multiplex FISH, spectral karyotyping, and comparative genomic hybridizat
19                     We used a combination of spectral karyotyping, array comparative genomic hybridiz
20 -reconstruction, whole-genome sequencing and spectral karyotyping-based single-cell phylogenetic tree
21 hniques, fluorescence in-situ hybridization, spectral karyotyping, comparative genomic hybridization,
22 ultiplex fluorescence in situ hybridization, spectral karyotyping, cross-species color banding, and c
23                                              Spectral karyotyping data showed several chromosomal abe
24 opment of powerful cytogenetic tools such as spectral karyotyping, fluorescence in situ hybridization
25 ls was then assessed by chromosome counting, spectral karyotyping, fluorescence in situ hybridization
26                                              Spectral karyotyping identified multiple chromosomal rea
27  five assays against ground truth defined by spectral karyotyping, in addition to comparing the conco
28 an fibroblast (TIELF) cells by G banding and spectral karyotyping indicated that forced extension of
29                  In addition, as revealed by spectral karyotyping, LMP1 induced "outre" giant cells a
30   We have developed a novel approach, termed spectral karyotyping or SKY based on the hybridization o
31                                              Spectral karyotyping revealed a complex rearrangement di
32 lomere fluorescent in-situ hybridization and spectral karyotyping revealed that nine out of nine lymp
33                                  Strikingly, spectral karyotyping (SKY) analysis revealed that loss o
34 did not display cytogenetic abnormalities by spectral karyotyping (SKY) analysis.
35                                              Spectral karyotyping (SKY) and fluorescent-in-situ hybri
36 Multicolor karyotyping technologies, such as spectral karyotyping (SKY) and multiplex (M-) FISH, have
37 e invasive and metastatic phenotype, we used spectral karyotyping (SKY) in combination with comparati
38                  This notion is supported by spectral karyotyping (SKY) of metaphase chromosomes, whi
39 tailed chromosomal analysis using multicolor spectral karyotyping (SKY) revealed that there were mult
40 ther recurring translocations in MM, we used spectral karyotyping (SKY) to analyze a panel of nine bo
41                              We have applied spectral karyotyping (SKY) to chemically induced plasmoc
42                       Here we use multicolor spectral karyotyping (SKY) to evaluate 10 established BA
43 is of chromosomal aberrations, using CGH and spectral karyotyping (SKY) was performed in our recently
44                                   Multicolor spectral karyotyping (SKY) was performed on bone marrow
45 ing comparative genomic hybridization (CGH), spectral karyotyping (SKY), and fluorescence in situ hyb
46                           We used G-banding, spectral karyotyping (SKY), and locus- and region-specif
47                                              Spectral karyotyping (SKY), and the related multiplex fl
48 ocarcinoma cell line HeLa through the use of spectral karyotyping (SKY), comparative genomic hybridiz
49          The molecular cytogenetic technique spectral karyotyping (SKY), on the other hand, enables c
50  of T-cell acute lymphoblastic leukemia with spectral karyotyping (SKY), which can identify all chrom
51 comparative genomic hybridization (CGH), and spectral karyotyping (SKY).
52 tion, comparative genomic hybridization, and spectral karyotyping to a series of nine established cel
53                                 We have used spectral karyotyping to assess potential roles of three
54 ined with classical cytogenetic analysis and spectral karyotyping to investigate the chromosomal segr
55                                      We used spectral karyotyping to provide a detailed analysis of k
56            In search of a related mechanism, spectral karyotyping was carried out, showing premature
57 ing, fluorescence in situ hybridization, and spectral karyotyping, we identified structural aberratio
58                   New technologies such as a spectral karyotyping will likely increase out ability to